Santos-Rosa, H.* ; Millán-Zambrano, G.* ; Han, N.* ; Leonardi, T.* ; Klimontova, M.* ; Nasiscionyte, S. ; Pandolfini, L.* ; Tzelepis, K.* ; Bartke, T. ; Kouzarides, T.*
Methylation of histone H3 at lysine 37 by Set1 and Set2 prevents spurious DNA replication.
Mol. Cell 81, 2793-2807.e8 (2021)
DNA replication initiates at genomic locations known as origins of replication, which, in S. cerevisiae, share a common DNA consensus motif. Despite being virtually nucleosome-free, origins of replication are greatly influenced by the surrounding chromatin state. Here, we show that histone H3 lysine 37 mono-methylation (H3K37me1) is catalyzed by Set1p and Set2p and that it regulates replication origin licensing. H3K37me1 is uniformly distributed throughout most of the genome, but it is scarce at replication origins, where it increases according to the timing of their firing. We find that H3K37me1 hinders Mcm2 interaction with chromatin, maintaining low levels of MCM outside of conventional replication origins. Lack of H3K37me1 results in defective DNA replication from canonical origins while promoting replication events at inefficient and non-canonical sites. Collectively, our results indicate that H3K37me1 ensures correct execution of the DNA replication program by protecting the genome from inappropriate origin licensing and spurious DNA replication.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
H3k37methylation ; Histone Modifications ; Mcm ; Origin Licensing ; Replication Origins ; Set1 ; Set2; Compass Family; Origin; Initiation; Proteins; Yeast; Acetylation; Chromatin; Program; Methyltransferase; Reveals
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
1097-2765
e-ISSN
1097-4164
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 81,
Heft: 13,
Seiten: 2793-2807.e8
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502800-001
Förderungen
Helmholtz Association
European Research Council (ERC)
Sir Henry Wellcome Fellowship
Asociacion Espanola Contra el Cancer
European Molecular Biology Organization (EMBO)
Wellcome Trust
Cancer Research UK
Copyright
Erfassungsdatum
2021-06-18